Improved time to quality of life deterioration in patients with progressive midgut neuroendocrine tumors treated with 177Lu-DOTATATE: The NETTER-1 phase III trial

Abstract

Open access

Peer reviewed

J. Strosberg, E. M. Wolin, B. Chasen, M. H. Kulke, D. Bushnell, M. Caplin, R. P. Baum, P. Kunz, T. Hobday, A. Hendifar, …

Annals of oncology, Vol.28(S5), pp.v146-v146

2017

DOI: 10.1093/annonc/mdx368.010

Files and links (1)

url

https://doi.org/10.1093/annonc/mdx368.010View

Published (Version of record) Open Access

Clinical Medicine

Cancer and Oncology

Cancer och onkologi

Klinisk medicin

Medical and Health Sciences

Medicin och hälsovetenskap

Title: Subtitle: Improved time to quality of life deterioration in patients with progressive midgut neuroendocrine tumors treated with 177Lu-DOTATATE: The NETTER-1 phase III trial
Creators: J. Strosberg - Moffitt Cancer Center
E. M. Wolin - Albert Einstein College of Medicine
B. Chasen - The University of Texas MD Anderson Cancer Center
M. H. Kulke - Dana-Farber Cancer Institute
D. Bushnell - University of Iowa
M. Caplin - The Royal Free Hospital
R. P. Baum - Zentralklinik Bad Berka
P. Kunz - Stanford University
T. Hobday - Mayo Clinic
A. Hendifar - Cedars-Sinai Medical Center
Kjell Öberg - Uppsala University Hospital
M. Lopera Sierra - Advanced Applications
P. Ruszniewski - Beaujon Hospital
E. Krenning - Erasmus MC
Resource Type: Abstract
Publication Details: Annals of oncology, Vol.28(S5), pp.v146-v146
DOI: 10.1093/annonc/mdx368.010
ISSN: 0923-7534
eISSN: 1569-8041
Language: English
Date published: 2017
Academic Unit: Radiology
Record Identifier: 9984320091802771

10 Record Views